Systems and methods for isolating and using clinically safe adipose derived regenerative cells
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-005/00
A61K-035/28
A61B-017/00
A61M-001/00
C12M-001/00
C12N-005/0775
출원번호
US-0452349
(2012-04-20)
등록번호
US-8883499
(2014-11-11)
발명자
/ 주소
Hedrick, Marc H.
Fraser, John K.
Schulzki, Michael J.
Byrnes, Bobby
Carlson, Grace
Schreiber, Ronda Elizabeth
Wulur, Isabella
출원인 / 주소
Cytori Therapeutics, Inc.
대리인 / 주소
Knobbe Martens Olson & Bear LLP
인용정보
피인용 횟수 :
11인용 특허 :
108
초록▼
Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g., stem and/or progenitor cells, from adipose tissue. The systems and methods described herein provide rap
Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g., stem and/or progenitor cells, from adipose tissue. The systems and methods described herein provide rapid and reliable methods of separating and concentrating regenerative cells suitable for re-infusion into a subject.
대표청구항▼
1. An automated cell processing unit for isolating a concentrated cell population comprising CD31 positive cells from adipose tissue, wherein said cell processing unit is configured to maintain a closed system, comprising: a tissue collection chamber that is configured to receive a first portion of
1. An automated cell processing unit for isolating a concentrated cell population comprising CD31 positive cells from adipose tissue, wherein said cell processing unit is configured to maintain a closed system, comprising: a tissue collection chamber that is configured to receive a first portion of unprocessed adipose tissue from said subject while maintaining a closed system, wherein said tissue collection chamber comprises an aspiration port;a first filter that is disposed within said tissue collection chamber, wherein said first filter is configured to substantially retain a first component of said unprocessed adipose tissue and substantially pass a second component of said unprocessed adipose tissue, such that said first filter substantially separates said first component from said second component, and wherein said first component comprises a cell population that comprises adipose-derived stem cells and said second component comprises lipid, blood, mature adipocytes and washing solution;a processing chamber that is joined to said tissue collection chamber by a conduit such that a closed system is maintained, wherein said processing chamber comprises a first filter, a centrifuge, or a spinning membrane filter, or any combination thereof;a programmable processing device capable of communication with said tissue collection chamber and said processing chamber, wherein said processing device operates a vacuum or a pump configured to use pressure to control ingress and egress of tissues through said automated cell processing unit; andan outlet wherein said outlet is configured to allow the aseptic removal of a concentrated population comprising CD31 positive cells obtained from said processing chamber. 2. The automated cell processing unit of claim 1, wherein said automated cell processing unit is configured to mechanically or enzymatically disaggregate said adipose tissue. 3. The automated cell processing unit of claim 1, wherein the programmable processing device comprises software to allow for collection of a set of run data selected from the group consisting of: a lot number of a reagent, a temperature measurement, a volume measurement, a tissue volume measurement a dose of enzyme introduced into the device; an operator identity; a patient identity, and an incubation time. 4. The automated cell processing unit of claim 1, wherein said automated cell processing unit comprises a disposable component and a hardware component. 5. The automated cell processing unit of claim 4, wherein the disposable component comprises the collection chamber. 6. The automated cell processing unit of claim 4, wherein the hardware component comprises a centrifuge. 7. The automated cell processing unit of claim 1, further comprising: a probe that can connect to at least one of said tissue collection chamber, said processing chamber, said cell concentrator, or a conduit that connects the tissue collection chamber and the cell processing chamber while maintaining a closed system. 8. The automated cell processing unit of claim 7, wherein said probe comprises a sensor. 9. The automated cell processing unit of claim 8, wherein said sensor is selected from the group consisting of an optical sensor, an ultrasonic sensor, and a pressure sensor. 10. The automated cell processing unit of claim 7, wherein said sensor is configured to detect the presence of red blood cells. 11. A method of processing adipose tissue to produce a concentrated population of cells comprising CD31 positive cells, comprising introducing adipose tissue that comprises a population of cells comprising CD31 positive cells into the automated cell processing unit of claim 1; andprocessing said adipose tissue to obtain a concentrated population of cells comprising adipose-derived CD31-positive cells. 12. The method of claim 11, further comprising a disaggregation step, wherein said adipose tissue is mechanically or enzymatically disaggregated. 13. The method of claim 12, wherein said disaggregation step comprises an enzymatic digestion. 14. The method of claim 13, wherein said enzymatic digestion comprises collagenase treatment. 15. The method of claim 13, wherein said enzymatic digestion comprises treatment with a neutral protease. 16. The method of claim 13, wherein said enzymatic digestion is inhibited by human serum. 17. The method of claim 11, wherein said automated cell processing unit comprises a probe that comprises a sensor. 18. The method of claim 17, wherein said sensor is selected from the group consisting of an optical sensor, an ultrasonic sensor, and a pressure sensor. 19. The method of claim 17, wherein said sensor is configured to detect the presence of red blood cells in said sample. 20. The method of claim 11, further comprising: receiving an input from a user that identifies whether said concentrated population of cells comprising adipose-derived CD31-positive cells will be administered intravascularly, non-systemically, or both; anddetermining the presence of at least one factor selected from the group consisting of adipocytes, free lipids, a proteolytic substance, a platelet aggregating substance, and an endotoxin in said concentrated population of cells comprising CD31-positive cells. 21. The method of claim 20, wherein the presence of an endotoxin, a proteolytic enzyme, a platelet aggregating substance, or free lipids is determined when the input received from said user identifies that said concentrated population of cells comprising CD31-positive cells will be administered intravascularly. 22. The method of claim 21, wherein said determining step is automatically performed. 23. The method of claim 21, wherein said determining step is not automatically performed. 24. The automated cell processing unit of claim 5, wherein said collection chamber comprises a flexible bag. 25. The automated cell processing unit of claim 1, further comprising a support for said collection chamber, said support comprising an internal frame or an external frame. 26. The automated cell processing unit of claim 1, wherein the collection chamber is configured to receive between 5 ml and 2 liters of adipose tissue. 27. The automated cell processing unit of claim 1, further comprising an agitation mechanism that agitates the collection chamber.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (108)
Goldman Stephen A. (Cincinnati OH) Retzsch Herbert L. (Cincinnati OH) Mansfield Todd L. (Cincinnati OH), Absorbent members for body fluids having good wet integrity and relatively high concentrations of hydrogel-forming absor.
Katz, Adam J.; Llull, Ramon; Futrell, William J.; Hedrick, Marc H.; Benhaim, Prosper; Lorenz, Hermann Peter; Zhu, Min, Adipose-derived stem cells and lattices.
Giesler Richard ; Chapman John R. ; Ellis Dale R. ; Bischof Daniel F., Apparatus for separation of biologic components from heterogeneous cell populations.
Hedrick, Marc H.; Fraser, John K.; Schulzki, Michael J.; Byrnes, Bobby; Carlson, Grace; Schreiber, Ronda Elizabeth; Wulur, Isabella, Automated methods for isolating and using clinically safe adipose derived regenerative cells.
Wolinsky Harvey (New York NY) King Spencer L. (Atlanta GA) Barbere Michael D. (Dunstable MA), Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen.
Lindall Arnold W. (1150 Nordic Ave. North ; P.O. Box 187 Stillwater MN 55082), Catheter system for controllably releasing a therapeutic agent at a remote tissue site.
Dwulet Francis E. ; Smith Marilyn E., Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease.
Lake William C. (Laguna Niguel CA) Giesler Richard (Deerfield IL) Epps Dennis Van (Cary IL) Chapman John R. (Lake Villa IL) Martinson Jeffrey A. (Mundelein IL) Ellis Dale R. (Wonder Lake IL) Aono Fre, Continuous centrifugation process for the separation of biological components from heterogeneous cell populations.
Lake William C. ; Giesler Richard ; Van Epps Dennis ; Chapman John R. ; Martinson Jeffrey A. ; Ellis Dale R. ; Aono Frederick ; Bischof Daniel F., Continuous process for the separation of biologic components from heterogeneous cell populations.
Alchas Paul G. (29 Ponds Cir. Wayne NJ 07470) Prais Alfred W. (245 Awosting Rd. Hewitt NJ 07421) Jarrell Bruce E. (5700 N. Via Elena Tucson AZ 85718) Williams Stuart K. (5181 N. Circulo Sobrio Tucson, Device and method for collecting and processing fat tissue and procuring microvessel endothelial cells to produce endoth.
Alchas Paul G. (Wayne NJ) Augello Frank A. (Cedar Knolls NJ) Brooks Christopher J. (Glen Cove NY) Cutshall Tony A. (Boonton NJ) DiPisa ; Jr. Joseph A. (Wyckoff NJ) Williams Stuart K. (Wilmington DE) , Endothelial cell procurement and deposition kit.
Alchas, Paul G.; Augello, Frank A.; Brooks, Christopher J.; Cutshall, Tony A.; DiPisa, Jr., Joseph A.; Williams, Stuart K.; Gabel, Jonathan B.; Mulhauser, Paul J.; Prais, Wes; Jarrell, Bruce E.; Rose, Endothelial cell procurement and deposition kit.
Caplan Arnold I. ; Haynesworth Stephen E. ; Gerson Stanton L. ; Lazarus Hillard M., Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells.
Weiss Samuel,CAX ; Reynolds Brent,CAX ; Hammang Joseph P. ; Baetge E. Edward, In vitro growth and proliferation of multipotent neural stem cells and their progeny.
Peterson Dale R. ; Nousek-Goebl Nancy, Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration.
Dubrul Will R. (P.O. Box 1211 Santa Barbara CA 93103) Elliott Martin P. (250 Hazel Dr. Corona Del Mar CA 92625), Liposuction filter and lipoplasty device.
Sheng Ping Zhong ; Arthur R. Madenjian ; Douglas E. Godshall ; John M. Ronan ; Samuel A. Thompson, Medical devices comprising hydrogel polymers having improved mechanical properties.
Humes H. David (Ann Arbor MI) Cieslinski Deborah A. (Ann Arbor MI), Method and compositions of a bioartificial kidney suitable for use in vivo or ex vivo.
McNally Robert T. (Marietta GA) McCaa Cameron (Marietta GA) Brockbank Kelvin G. M. (Marietta GA) Heacox Albert E. (Marietta GA) Bank Harvey L. (Charleston SC), Method for cryopreserving blood vessels.
Eppley Barry L. (8360 Lakeshore Cir. Indianapolis IN 46250) Krukowski Marilyn D. (24 Washington Ter. St. Louis MO 63112) Osdoby Philip A. (16206 Berry Hollow Ct. Ballwin MO 63011), Method for promoting soft connective tissue growth and repair in mammals.
Caplan Arnold I. (1300 Oakridge Dr. Cleveland Heights OH 44121) Haynesworth Stephen E. (3643 Antisdale Rd. Cleveland Heights OH 44118), Method for treating connective tissue disorders.
Yannas Ioannis V. (Newton Center MA) Burke John F. (Belmont MA) Orgill Dennis P. (Cambridge MA) Skrabut Eugene M. (Beverly MA), Method of promoting the regeneration of tissue at a wound.
Carabasi R. Anthony (Bryn Mawr PA) Jarrell Bruce E. (Philadelphia PA) Williams Stuart K. (Wilmington DE), Method of reendothelializing vascular linings.
Williams Stuart K. (Wilmington DE) Jarrell Bruce E. (Philadelphia PA), Method of treating a synthetic naturally occurring surface with a collagen laminate to support microvascular endothelial.
Williams Stuart K. (Drexel Hill PA) Jarrell Bruce E. (Philadelphia PA), Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surfa.
Lacy Paul E. (63 Marshall Pl. St. Louis MO 63119) Scharp David W. (1469 Willow Brook Cove St. Louis MO 63146) Ricordi Camillo (Corso Porta Nuova 10 20121 Milano ITX), Method to isolate clusters of cell subtypes from organs.
Hedrick, Marc H.; Fraser, John K.; Riley, Susan Lynn; Schreiber, Ronda Elizabeth, Methods of using regenerative cells in the treatment of musculoskeletal disorders.
Hu Can B. (Irvine CA) Ma Minh T. (Santa Ana CA) Nguyen Than (Huntington Beach CA) Rhee Richard (Diamond Bar CA) Myers Keith (El Toro CA), Microvessel cell isolation apparatus.
Tayot Jean-Louis (La Tour de Salvagny FRX) Tardy Michel (Lyons FRX), New preparation of placenta collagen, their extraction method and their applications.
Helmut Burtscher DE; Dorothee Ambrosius DE; Friederike Hesse DE, Recombinant collagenase type I from clostridium histolyticum and its use for isolating cells and groups of cells.
MacPhee Martin James ; Drohan William Nash ; Lasa ; Jr. Carlos I.,PHX ; Liau Gene ; Haudenschild Christian, Supplemented and unsupplemented tissue sealants, methods of their production and use.
Haller, Markus; Ferek-Petric, Bozidar; Donders, Adrianus P., System and method of communicating between an implantable medical device and a remote computer system or health care provider.
Hedrick, Marc H.; Fraser, John K.; Schulzki, Michael J.; Byrnes, Bobby; Carlson, Grace; Schreiber, Ronda; Wulur, Isabella, Systems and methods for isolating and using clinically safe adipose derived regenerative cells.
Hedrick, Marc H.; Fraser, John K.; Schulzki, Michael J.; Byrnes, Bobby; Carlson, Grace; Shanahan, Robert K., Systems and methods for separating and concentrating adipose derived stem cells from tissue.
Gerson Stanton L. (Pepper Pike OH) Caplan Arnold I. (Cleveland Heights OH) Haynesworth Stephen E. (Cleveland Heights OH), Transduced mesenchymal stem cells.
Yuan-Di C. Halvorsen ; William O. Wilkison ; Jeffrey Martin Gimble, Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair.
Clarke Rolf W. (Balboa Island CA) Balding David P. (Mission Viejo CA) Gordon Lucas S. (Lagune Beach CA), Venous reservoir bag with integral high-efficiency bubble removal system.
Hedrick, Marc H.; Fraser, John K.; Riley, Susan Lynn; Schreiber, Ronda Elizabeth, Methods of using adipose derived regenerative cells to promote restoration of intevertebral disc.
Fraser, John K.; Hedrick, Marc H.; Zhu, Min; Strem, Brian M.; Daniels, Eric; Wulur, Isabella, Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions.
Hedrick, Marc H.; Fraser, John K.; Schulzki, Michael J.; Byrnes, Bobby; Carlson, Grace; Schreiber, Ronda Elizabeth; Wulur, Isabella, Systems for isolating and using clinically safe adipose derived regenerative cells.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.